Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pragya Kumar

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Mediterranean Journal of Rheumatology|January 29, 2026
Diagnostic Performance of ANCA Testing Across Three Platforms with and without Coexisting ANA Positivity: Experience from a Tertiary Healthcare Centre in IndiaNeha Rai, Shamshad Ahmad, Saurabh Karmakar, et al.
PLOS Global Public Health|August 21, 2023
Point-of-care prognostication in moderate Covid-19: Analytical validation and prognostic accuracy of a soluble urokinase plasminogen activator receptor (suPAR) rapid testArjun Chandna, Raman Mahajan, Priyanka Gautam, et al.
BMC Health Services Research|January 26, 2025
Exploring the role of the JEEViKA swasthya mitra helpdesk in improving healthcare access: a qualitative study in tertiary healthcare facilities in Bihar, IndiaPragya Kumar, Shamshad Ahmad, Narottam Pradhan, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Pharmacokinetic Acceleration via CYP3A4 Hyperactivation as a Clinically Actionable Mechanism of Targeted Therapy Resistance in NSCLCPragya Kumar, Menkara Henry, Julia Pelesko, et al.
Research Square|May 2, 2025
Multifactorial stroma-mediated resistance is a major contributor to residual disease under targeted therapies in lung cancersBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
Nature Communications|May 29, 2026
Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapiesBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
BMC Medical Education|December 28, 2024
Designing a summative assessment blueprint in community medicine: an expert consensus approach at All India Institute of Medical SciencesPragya Kumar, Neha Chaudhary, Arun Mahadeo Kokane, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2023
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse modelsMeenal Datta, Sampurna Chatterjee, Elizabeth M Perez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2022
Facilitating Safe Discharge Through Predicting Disease Progression in Moderate Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study to Develop and Validate a Clinical Prediction Model in Resource-Limited SettingsArjun Chandna, Raman Mahajan, Priyanka Gautam, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Mediterranean Journal of Rheumatology|January 29, 2026
Diagnostic Performance of ANCA Testing Across Three Platforms with and without Coexisting ANA Positivity: Experience from a Tertiary Healthcare Centre in IndiaNeha Rai, Shamshad Ahmad, Saurabh Karmakar, et al.
PLOS Global Public Health|August 21, 2023
Point-of-care prognostication in moderate Covid-19: Analytical validation and prognostic accuracy of a soluble urokinase plasminogen activator receptor (suPAR) rapid testArjun Chandna, Raman Mahajan, Priyanka Gautam, et al.
BMC Health Services Research|January 26, 2025
Exploring the role of the JEEViKA swasthya mitra helpdesk in improving healthcare access: a qualitative study in tertiary healthcare facilities in Bihar, IndiaPragya Kumar, Shamshad Ahmad, Narottam Pradhan, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Pharmacokinetic Acceleration via CYP3A4 Hyperactivation as a Clinically Actionable Mechanism of Targeted Therapy Resistance in NSCLCPragya Kumar, Menkara Henry, Julia Pelesko, et al.
Research Square|May 2, 2025
Multifactorial stroma-mediated resistance is a major contributor to residual disease under targeted therapies in lung cancersBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
Nature Communications|May 29, 2026
Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapiesBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
BMC Medical Education|December 28, 2024
Designing a summative assessment blueprint in community medicine: an expert consensus approach at All India Institute of Medical SciencesPragya Kumar, Neha Chaudhary, Arun Mahadeo Kokane, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2023
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse modelsMeenal Datta, Sampurna Chatterjee, Elizabeth M Perez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2022
Facilitating Safe Discharge Through Predicting Disease Progression in Moderate Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study to Develop and Validate a Clinical Prediction Model in Resource-Limited SettingsArjun Chandna, Raman Mahajan, Priyanka Gautam, et al.
Pageof 6